ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

ADAMTS13 levels in a plasma-derived FVIII concentrate: A potential therapeutic option for patients with congenital thrombotic thrombocytopenic purpura

Published:2022-12 Issue: Volume:9 Page:100120
ISSN:2666-5727
Container-title:Thrombosis Update
language:en
Short-container-title:Thrombosis Update

Author:

Mori Filippo^ORCID,Nardini Ilaria,Nannizzi Silvia,Crea Roberto,Mathew Prasad,Ziliotto Nicole,Gringeri Alessandro

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Hematology

Reference38 articles.

1. Regional UK TTP registry: correlation with laboratory ADAMTS 13 analysis and clinical features;Scully;Br. J. Haematol.,2008

2. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy, the Lancet;Mariotte;Haematology,2016

3. Polymorphisms and mutations of ADAMTS13 in the Japanese population and estimation of the number of patients with Upshaw-Schulman syndrome;Kokame;J. Thromb. Haemostasis : JTH,2011

4. The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry;Hassan;Br. J. Haematol.,2015

5. What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura, Hematology;Sadler;Am. Soc. Hematol. Ed. Program,2015

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term follow‐up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma‐derived factor VIII (Koate) that contains ADAMTS13;Haemophilia;2023-10-19